» Articles » PMID: 29409569

Seasonality and Geographical Spread of Respiratory Syncytial Virus Epidemics in 15 European Countries, 2010 to 2016

Overview
Journal Euro Surveill
Date 2018 Feb 8
PMID 29409569
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is considered the most common pathogen causing severe lower respiratory tract infections among infants and young children. We describe the seasonality and geographical spread of RSV infection in 15 countries of the European Union and European Economic Area. We performed a retrospective descriptive study of weekly laboratory-confirmed RSV detections between weeks 40/2010 and 20/2016, in patients investigated for influenza-like illness, acute respiratory infection or following the clinician's judgment. Six countries reported 4,230 sentinel RSV laboratory diagnoses from primary care and 14 countries reported 156,188 non-sentinel laboratory diagnoses from primary care or hospitals. The median length of the RSV season based on sentinel and non-sentinel surveillance was 16 (range: 9-24) and 18 (range: 8-24) weeks, respectively. The median peak weeks for sentinel and non-sentinel detections were week 4 (range: 48 to 11) and week 4.5 (range: 49 to 17), respectively. RSV detections peaked later (r = 0.56; p = 0.0360) and seasons lasted longer with increasing latitude (r = 0.57; p = 0.0329). Our data demonstrated regular seasonality with moderate correlation between timing of the epidemic and increasing latitude of the country. This study supports the use of RSV diagnostics within influenza or other surveillance systems to monitor RSV seasonality and geographical spread.

Citing Articles

Assessing the Impact of Non-Pharmaceutical Interventions During the COVID-19 Pandemic on RSV Seasonality in Europe.

Heemskerk S, Baliatsas C, Stelma F, Nair H, Paget J, Spreeuwenberg P Influenza Other Respir Viruses. 2025; 19(1):e70066.

PMID: 39838552 PMC: 11750802. DOI: 10.1111/irv.70066.


[Epidemiological characteristics of respiratory syncytial virus infection in children in Nanchang and its correlation with climate environmental factors].

Luo X, Chen Q, Li L, Zhu X, Huang P, Wang J Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(12):1282-1287.

PMID: 39725390 PMC: 11684828. DOI: 10.7499/j.issn.1008-8830.2406109.


Variability in the Timing of Respiratory Syncytial Virus Epidemics in Guatemala, 2008-2018.

Hamid S, Grajeda L, de Leon O, Lopez M, Maldonado H, Gomez A Influenza Other Respir Viruses. 2024; 18(7):e13334.

PMID: 38980961 PMC: 11232890. DOI: 10.1111/irv.13334.


How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?.

Martinon-Torres F, Gutierrez C, Caceres A, Weber K, Torres A Influenza Other Respir Viruses. 2024; 18(6):e13341.

PMID: 38923767 PMC: 11194680. DOI: 10.1111/irv.13341.


Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.

Holmdahl I, Bents S, Baker R, Casalegno J, Trovao N, Park S Sci Rep. 2024; 14(1):14527.

PMID: 38914626 PMC: 11196647. DOI: 10.1038/s41598-024-64624-1.


References
1.
Homaira N, Rawlinson W, Snelling T, Jaffe A . Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective. Int J Pediatr. 2014; 2014:571609. PMC: 4274815. DOI: 10.1155/2014/571609. View

2.
Terletskaia-Ladwig E, Enders G, Schalasta G, Enders M . Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study. BMC Infect Dis. 2005; 5:20. PMC: 1084247. DOI: 10.1186/1471-2334-5-20. View

3.
Higgins D, Trujillo C, Keech C . Advances in RSV vaccine research and development - A global agenda. Vaccine. 2016; 34(26):2870-2875. DOI: 10.1016/j.vaccine.2016.03.109. View

4.
Zwaans W, Mallia P, van Winden M, Rohde G . The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review. J Clin Virol. 2014; 61(2):181-8. PMC: 7106508. DOI: 10.1016/j.jcv.2014.06.025. View

5.
Anestad G . Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference. Epidemiol Infect. 1987; 99(2):523-31. PMC: 2249295. DOI: 10.1017/s0950268800068023. View